PurposeTo compare the short term effects of bevacizumab and ranibizumab injections on the regression of corneal neovascularization (NV).MethodsSixteen eyes of 16 patients with corneal NV were randomly assigned for an injection with 2.5 mg of bevacizumab (group 1, n = 8) or 1 mg of ranibizumab (group 2, n = 8) through subconjunctival and intrastromal routes. The patients were prospectively followed-up for one month after the injections. Corneal NV areas, as shown on corneal slit-lamp photographs stored in JPEG format, were calculated using Image J software before the injection, one week after the injection, and one month after the injection. The corneal NV areas were compared before and after the injections.ResultsSeven women and nine men, with an average age of 51 years, presented with corneal NV secondary to herpetic keratitis (7 cases), graft rejection (6), chemical burn (1), pemphigoid (1), and recurrent ulcer (1). In group I, the preoperative corneal NV area (8.75 ± 4.33%) was significantly decreased to 5.62 ± 3.86% one week after the injection and to 6.35 ± 3.02% one month after the injection (p = 0.012, 0.012, respectively). The corneal NV area in group 2 also exhibited a significant change, from 7.37 ± 4.33% to 6.72 ± 4.16% one week after the injection (p = 0.012). However, no significant change was observed one month after the injection. The mean decrease in corneal NV area one month after injection in group 1 (28.4 ± 9.01%) was significantly higher than in group 2 (4.51 ± 11.64%, p = 0.001).ConclusionsBevacizumab injection resulted in a more effective and stable regression of corneal NV compared to the ranibizumab injection. The potency and dose of these two drugs for the regression of corneal NV require further investigation.

CBD size could be determined using a CMR implanted during surgery. AL and ACD were predictors of postoperative CBD. Predicting CBD in this way may assist in selecting appropriately sized IOL, which will lead to improved visual quality after cataract surgery.

No abstract

Femtosecond laser-assisted corneal biopsy enabled identification of the infectious pathogen in both patients. This technique is easy, safe, and rapid, and it yields a biopsy specimen with a uniform depth and precise size. Femtosecond laser-assisted corneal biopsy can be used as an accurate diagnostic method in uncertain cases of corneal ulcers.

A 43-year-old woman had laser in situ keratomileusis (LASIK) using the IntraLase femtosecond laser (IntraLASIK) to create 110 microm flaps. Despite uneventful flap formation, the flaps in both eyes were extremely thin, making it difficult to lift them. The flap in the right eye resembled an epi-LASIK epithelial flap. It was lifted uneventfully. The flap in the left eye was stretched and torn on lifting, and the procedure was therefore postponed. After 6 months, the IntraLASIK surgical procedure was repeated in the left eye using a thicker and smaller flap than in the first procedure. Despite the improvements associated with using an IntraLase femtosecond laser, thinner-than-intended corneal flaps can occur. Early recognition of such a flap can prevent further complications.